Redwood City, CA, United States of America

Paul Blaine Mesko

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Paul Blaine Mesko: Innovator in Antibody Development

Introduction

Paul Blaine Mesko is a notable inventor based in Redwood City, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work focuses on innovative solutions that have the potential to impact medical diagnostics and treatment.

Latest Patents

One of Paul Blaine Mesko's key patents is titled "Anti-IDO antibody and uses thereof." This patent provides antibodies that specifically bind to human IDO and outlines methods for their use. The disclosure includes methods for detecting IDO in a biological sample by contacting the sample with the described antibodies. This innovation holds promise for advancing medical research and therapeutic applications.

Career Highlights

Paul Blaine Mesko is currently associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His role at the company allows him to contribute to groundbreaking research and development in the field of pharmaceuticals. His expertise in antibody development is a valuable asset to the organization.

Collaborations

Throughout his career, Paul has collaborated with talented individuals such as Anan Chuntharapai and Thomas E Spires, Jr. These collaborations have fostered a productive environment for innovation and have led to advancements in their respective fields.

Conclusion

In summary, Paul Blaine Mesko is a distinguished inventor whose work in antibody development has the potential to make a significant impact in the medical field. His contributions, particularly through his patent on anti-IDO antibodies, highlight his commitment to advancing biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…